Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOP for Granule Size Distribution

Posted on By

Standard Operating Procedure for Granule Size Distribution

Purpose

The purpose of this SOP is to define the procedures for determining granule size distribution during the tablet/ capsule manufacturing process to ensure product quality and consistency.

Scope

This SOP applies to all personnel involved in the tablet/ capsule manufacturing process, specifically those responsible for assessing granule size distribution.

Responsibilities

  • Quality Control Analysts: Responsible for conducting granule size distribution analysis according to this SOP.
  • Production Department: Providing granule samples for testing and cooperating with quality control personnel.
  • Quality Assurance Department: Ensuring compliance with regulatory standards and guidelines.

Procedure

  1. Collect representative samples of granules from the manufacturing process.
  2. Prepare the samples for analysis by following established procedures for sample preparation.
  3. Use appropriate analytical techniques such as sieve analysis or laser diffraction to determine granule size distribution.
  4. Record and analyze the results obtained from the granule size distribution analysis.
  5. Compare the results against predefined acceptance criteria.
  6. Document all testing procedures, observations, and results accurately and comprehensively.
  7. Review and approve the test results by authorized personnel.
  8. Initiate corrective actions if deviations from acceptance criteria are identified.
See also  SOP for Syringe Plunger Force Testing

Abbreviations Used

SOP: Standard Operating Procedure
QC: Quality Control
QA: Quality Assurance

Documents

  • Granule Size Distribution Testing Protocol
  • Standard Operating Procedures Manual
  • Batch Records
  • Quality Control Reports
  • Deviation Reports

Reference

No specific references are cited for this SOP.

SOP Version

Version 1.0

In-Process Control Tags:Antioxidant Testing, Appearance Inspection, Assay Testing, Batch testing, Blend Homogeneity Testing, Blend Uniformity Testing, Clarity Testing, Coating Thickness Measurement, Compliance testing, Container Closure Integrity Testing, Content Uniformity Testing, Disintegration Testing, Dissolution Profile Analysis, Dissolution Testing, Endotoxin testing, Friability Testing, Granule Size Distribution Analysis, Hardness Testing, In-process control, Leakage Testing, Manufacturing standards, Microbial Testing, Moisture Content Determination, Osmolality Testing, Particle Size Distribution Analysis, pH Testing, Process validation, Quality Assurance, Quality Control, Real-time monitoring, Sterility testing, Uniformity of Dosage Units Testing, Viscosity Testing, Weight Variation Testing

Post navigation

Previous Post: In-Process Control: SOP forĀ Blend Uniformity Testing
Next Post: In-Process Control: SOP for Tablet Hardness TestingĀ 

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version